The efficacy and safety of a selective PARP1 inhibitor ACE-86225106 in patients with advanced solid tumors: Preliminary results from a first-in-human phase 1/2 study.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Jiongjie Chen, Jian Zhang, Zhanhong Chen, Yu Chen
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410823147